Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
    April 2024
  1. MEULEN LWT, Bogie RMM, Siersema PD, Winkens B, et al
    Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicentre cluster randomised trial.
    Gut. 2024;73:741-750.
    >> Share

    March 2024
  2. CHEN S, Xin J, Gu D, Li H, et al
    Smoking-related Lactobacillus and immune cell infiltration in colorectal cancer: evidence from a population-based study.
    Gut. 2024 Mar 18:gutjnl-2023-331865. doi: 10.1136/gutjnl-2023-331865.
    >> Share

    February 2024
  3. ABDELRAHIM M, Siggens K, Iwadate Y, Maeda N, et al
    New AI model for neoplasia detection and characterisation in inflammatory bowel disease.
    Gut. 2024 Feb 23:gutjnl-2023-330718. doi: 10.1136/gutjnl-2023-330718.
    >> Share

    January 2024
  4. TAGHIAKBARI M, Anderson JC, von Renteln D, Hirschmann S, et al
    Extent of normal polyp resection margin: a possible quality measure for polyp resection.
    Gut. 2024;73:216-218.
    >> Share

  5. CORONADO GD, Jenkins CL, Shuster E, Johnson C, et al
    Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence.
    Gut. 2024 Jan 4:gutjnl-2023-330980. doi: 10.1136/gutjnl-2023-330980.
    >> Share

    December 2023
  6. DJINBACHIAN R, Pohl H, Rex DK, Levenick JM, et al
    Thermal ablation after endoscopic mucosal resection of large colorectal polyps: not only the margins, but also the base?
    Gut. 2023;73:12-15.
    >> Share

    November 2023
  7. LI R, Liu X, Huang X, Zhang D, et al
    Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.
    Gut. 2023 Nov 30:gutjnl-2023-330243. doi: 10.1136/gutjnl-2023-330243.
    >> Share

  8. POOLER BD, Kim DH, Matkowskyj KA, Newton MA, et al
    Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal.
    Gut. 2023;72:2321-2328.
    >> Share

  9. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    >> Share

  10. DJINBACHIAN R, Khellaf A, Noyon B, Soucy G, et al
    Accuracy of measuring colorectal polyp size in pathology: a prospective study.
    Gut. 2023;72:2015-2018.
    >> Share

  11. TERLOUW D, Hes FJ, Suerink M, Boot A, et al
    APC mosaicism, not always isolated: two first-degree relatives with apparently distinct APC mosaicism.
    Gut. 2023;72:2186-2187.
    >> Share

    October 2023
  12. VAN DRIEL MS, Linssen JDG, van Neerven SM, Vermeulen L, et al
    Pleiotropic role of NOTUM in colorectal cancer.
    Gut. 2023 Oct 26:gutjnl-2023-330807. doi: 10.1136/gutjnl-2023-330807.
    >> Share

  13. TATE DJ, Desomer L, Argenziano ME, Mahajan N, et al
    Treatment of adenoma recurrence after endoscopic mucosal resection.
    Gut. 2023;72:1875-1886.
    >> Share

  14. REES CJ, Hamilton W
    BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose?
    Gut. 2023;72:1805-1806.
    >> Share

    September 2023
  15. FONG W, Li Q, Ji F, Liang W, et al
    Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.
    Gut. 2023 Sep 28:gutjnl-2023-329543. doi: 10.1136/gutjnl-2023-329543.
    >> Share

  16. CHURCHHOUSE AM, Moffat VE, Selinger CP, Lamb CA, et al
    British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.
    Gut. 2023;72:1631-1634.
    >> Share

  17. WINTERS C, Ford AC
    Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy.
    Gut. 2023;72:1799-1800.
    >> Share

    August 2023
  18. TIAN Y, Wang X, Cramer Z, Rhoades J, et al
    APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer.
    Gut. 2023 Aug 17:gutjnl-2022-329140. doi: 10.1136/gutjnl-2022-329140.
    >> Share

    July 2023
  19. KANG X, Liu C, Ding Y, Ni Y, et al
    Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells.
    Gut. 2023 Jul 25:gutjnl-2023-330291. doi: 10.1136/gutjnl-2023-330291.
    >> Share

  20. BRESALIER RS, Senore C, Young GP, Allison J, et al
    An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.
    Gut. 2023 Jul 18:gutjnl-2023-329701. doi: 10.1136/gutjnl-2023-329701.
    >> Share

  21. CHAN FKL, Wong MCS, Chan AT, East JE, et al
    Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.
    Gut. 2023;72:1240-1254.
    >> Share

  22. JIANG Y, Xu Y, Zheng C, Ye L, et al
    Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment.
    Gut. 2023;72:1308-1318.
    >> Share

    June 2023
  23. POTENZA A, Balestrieri C, Spiga M, Albarello L, et al
    Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.
    Gut. 2023 Jun 30:gutjnl-2022-328042. doi: 10.1136/gutjnl-2022-328042.
    >> Share

  24. GAMEZ-BELMONTE R, Mahapatro M, Erkert L, Gonzalez-Acera M, et al
    Epithelial presenilin-1 drives colorectal tumour growth by controlling EGFR-COX2 signalling.
    Gut. 2023;72:1155-1166.
    >> Share

    May 2023
  25. HAJJAR R, Fragoso G, Oliero M, Alaoui AA, et al
    Basal levels of microbiota-driven subclinical inflammation are associated with anastomotic leak in patients with colorectal cancer.
    Gut. 2023 May 3:gutjnl-2023-329929. doi: 10.1136/gutjnl-2023-329929.
    >> Share

  26. JUUL FE, Garborg K, Nesbakken E, Loberg M, et al
    Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials.
    Gut. 2023;72:951-957.
    >> Share

    April 2023
  27. TOES-ZOUTENDIJK E, de Jonge L, van Iersel CA, Spaander MCW, et al
    Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
    Gut. 2023 Apr 19:gutjnl-2022-328559. doi: 10.1136/gutjnl-2022-328559.
    >> Share

  28. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    >> Share

    March 2023
  29. HEISSER T, Hoffmeister M, Brenner H
    Significant underestimation of preventive effects in colorectal cancer screening trial.
    Gut. 2023 Mar 7:gutjnl-2022-329165. doi: 10.1136/gutjnl-2022-329165.
    >> Share

  30. VON RENTELN D, Djinbachian R, Zarandi-Nowroozi M, Taghiakbari M, et al
    Measuring size of smaller colorectal polyps using a virtual scale function during endoscopies.
    Gut. 2023;72:417-420.
    >> Share

    February 2023
  31. MORGAN E, Arnold M, Gini A, Lorenzoni V, et al
    Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.
    Gut. 2023;72:338-344.
    >> Share

  32. SAMADDER NJ, Foster N, McMurray RP, Burke CA, et al
    Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
    Gut. 2023;72:256-263.
    >> Share

    January 2023
  33. BAO Y, Zhai J, Chen H, Wong CC, et al
    Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.
    Gut. 2023 Jan 30:gutjnl-2022-328845. doi: 10.1136/gutjnl-2022-328845.
    >> Share

  34. ROTTOLI M, Gori A, Pellino G, Flacco ME, et al
    Is the significant risk of perioperative complications associated with radical surgery following non-curative endoscopic submucosal dissection for early colorectal cancer still acceptable?
    Gut. 2023 Jan 25:gutjnl-2022-328076. doi: 10.1136/gutjnl-2022-328076.
    >> Share

    December 2022
  35. HAJJAR R, Gonzalez E, Fragoso G, Oliero M, et al
    Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines.
    Gut. 2022 Dec 30:gutjnl-2022-328389. doi: 10.1136/gutjnl-2022-328389.
    >> Share

  36. GIBSON DJ, Sidhu M, Zanati S, Tate DJ, et al
    Oncological outcomes after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps with covert submucosal invasive cancer.
    Gut. 2022;71:2481-2488.
    >> Share

  37. VOSKO S, Shahidi N, Gupta S, van Hattem WA, et al
    'Fish-eye' polypectomy defect: a new sign during endoscopic mucosal resection?
    Gut. 2022;71:2413-2488.
    >> Share

    November 2022
  38. ROELANDS J, van der Ploeg M, Ijsselsteijn ME, Dang H, et al
    Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
    Gut. 2022 Nov 28:gutjnl-2022-327608. doi: 10.1136/gutjnl-2022-327608.
    >> Share

  39. ZORZI M, Battagello J, Barbiellini Amidei C
    Reply: Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy.
    Gut. 2022 Nov 4. pii: gutjnl-2022-328905. doi: 10.1136/gutjnl-2022-328905.
    >> Share

  40. DEY N
    Picking up microbial clues in early-onset colorectal cancer.
    Gut. 2022 Nov 2. pii: gutjnl-2022-328427. doi: 10.1136/gutjnl-2022-328427.
    >> Share

  41. LI C, Wang Y, Liu D, Wong CC, et al
    Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
    Gut. 2022;71:2253-2265.
    >> Share

    September 2022
  42. LI X, Pan J, Liu T, Yin W, et al
    Novel TCF21(high) pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix.
    Gut. 2022 Sep 7:gutjnl-2022-327913. doi: 10.1136/gutjnl-2022-327913.
    >> Share

    August 2022
  43. SUNG JJY, Chiu HM, Lieberman D, Kuipers EJ, et al
    Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance.
    Gut. 2022 Aug 24. pii: gutjnl-2022-327377. doi: 10.1136/gutjnl-2022-327377.
    >> Share

  44. KONG C, Liang L, Liu G, Du L, et al
    Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
    Gut. 2022 Aug 11. pii: gutjnl-2022-327156. doi: 10.1136/gutjnl-2022-327156.
    >> Share

    July 2022
  45. MONAHAN KJ, Davies MM, Abulafi M, Banerjea A, et al
    Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BS
    Gut. 2022 Jul 12. pii: gutjnl-2022-327985. doi: 10.1136/gutjnl-2022-327985.
    >> Share

  46. BONNEREAU J, Courau T, Asesio N, Salfati D, et al
    Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
    Gut. 2022 Jul 8. pii: gutjnl-2021-326553. doi: 10.1136/gutjnl-2021-326553.
    >> Share

    June 2022
  47. SULLIVAN KM, Jiang X, Guha P, Lausted C, et al
    Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases.
    Gut. 2022 Jun 15. pii: gutjnl-2021-325808. doi: 10.1136/gutjnl-2021-325808.
    >> Share

  48. FENNELL L, Kane A, Liu C, McKeone D, et al
    Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium.
    Gut. 2022;71:1127-1140.
    >> Share

  49. NAMMOUR T, Hamie L, Barada KA
    Polyps and skin lesions: what could it be?
    Gut. 2022;71:1061-1116.
    >> Share

    May 2022
  50. MEESTER RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, et al
    Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
    Gut. 2022 May 10. pii: gutjnl-2022-327188. doi: 10.1136/gutjnl-2022-327188.
    >> Share

  51. BUZIAU AM, Law PJ, Blokland G, Schalkwijk C, et al
    Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study.
    Gut. 2022 May 10. pii: gutjnl-2021-326299. doi: 10.1136/gutjnl-2021-326299.
    >> Share

  52. ASLAN J, Conley TE, Campbell F, Smith PJ, et al
    Recurrent colonic polyps.
    Gut. 2022;71:888-960.
    >> Share

    April 2022
  53. CORRY SM, McCorry AM, Lannagan TR, Leonard NA, et al
    Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
    Gut. 2022 Apr 27. pii: gutjnl-2021-326183. doi: 10.1136/gutjnl-2021-326183.
    >> Share

  54. WALJEE AK, Weinheimer-Haus EM, Abubakar A, Ngugi AK, et al
    Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa.
    Gut. 2022 Apr 13. pii: gutjnl-2022-327211. doi: 10.1136/gutjnl-2022-327211.
    >> Share

  55. JESS T, Vestergaard MV, Iversen AT, Allin KH, et al
    Undiagnosed inflammatory bowel disease among individuals undergoing colorectal cancer screening: a nationwide Danish cohort study 2014-2018.
    Gut. 2022 Apr 12. pii: gutjnl-2022-327296. doi: 10.1136/gutjnl-2022-327296.
    >> Share

  56. BAI X, Wei H, Liu W, Coker OO, et al
    Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites.
    Gut. 2022 Apr 6. pii: gutjnl-2021-325021. doi: 10.1136/gutjnl-2021-325021.
    >> Share

  57. REPICI A, Spadaccini M, Antonelli G, Correale L, et al
    Artificial intelligence and colonoscopy experience: lessons from two randomised trials.
    Gut. 2022;71:757-765.
    >> Share

  58. JIMENEZ-VARGAS NN, Yu Y, Jensen DD, Bok DD, et al
    Agonist that activates the micro-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
    Gut. 2022;71:695-704.
    >> Share

  59. HO JL, Vu C, Liang R, Ding C, et al
    Not your 'day-to-day' colonic polyps.
    Gut. 2022;71:675-715.
    >> Share

    March 2022
  60. HALLIT R, Barret M, Belle A, Abou Ali E, et al
    Appendoscopy in patients with serrated polyposis syndrome.
    Gut. 2022;71:653-654.
    >> Share

  61. HOUWEN BBSL, Hazewinkel Y, Pellise M, Rivero-Sanchez L, et al
    Linked Colour imaging for the detection of polyps in patients with Lynch syndrome: a multicentre, parallel randomised controlled trial.
    Gut. 2022;71:553-560.
    >> Share

  62. PAGANO E, Elias JE, Schneditz G, Saveljeva S, et al
    Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
    Gut. 2022;71:509-520.
    >> Share

  63. SI W, Liang H, Bugno J, Xu Q, et al
    Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.
    Gut. 2022;71:521-533.
    >> Share

    February 2022
  64. DHAWAN R, Shay D, Zhao YC, Lu Y, et al
    Comment on Murphy et al: maternal obesity, pregnancy weight gain, and birth weight and risk of colorectal cancer.
    Gut. 2022 Feb 23. pii: gutjnl-2022-327148. doi: 10.1136/gutjnl-2022-327148.
    >> Share

  65. ALDOORI J, Cockbain AJ, Toogood GJ, Hull MA, et al
    Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer.
    Gut. 2022 Feb 3. pii: gutjnl-2021-326362. doi: 10.1136/gutjnl-2021-326362.
    >> Share

  66. Correction: Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16.
    Gut. 2022;71:e1-e3.
    >> Share

  67. GUAN H, Zeng C, Chen Y
    Letter to editor: piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions.
    Gut. 2022;71:440.
    >> Share

  68. HUANG TX, Tan XY, Huang HS, Li YT, et al
    Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.
    Gut. 2022;71:333-344.
    >> Share

    January 2022
  69. TIAN S, Chu Y, Hu J, Ding X, et al
    Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Gut. 2022 Jan 27. pii: gutjnl-2021-325137. doi: 10.1136/gutjnl-2021-325137.
    >> Share

  70. SPADACCINI M, Bourke MJ, Maselli R, Pioche M, et al
    Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer.
    Gut. 2022 Jan 20. pii: gutjnl-2020-323897. doi: 10.1136/gutjnl-2020-323897.
    >> Share

    December 2021
  71. DONG C, Lee YH, Tan TY, Yao CC, et al
    Correspondence to proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326139. doi: 10.1136/gutjnl-2021-326139.
    >> Share

  72. ABRAHAMI D, Azoulay L
    Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326544. doi: 10.1136/gutjnl-2021-326544.
    >> Share

  73. CHIU HM, Jen GH, Wang YW, Fann JC, et al
    Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
    Gut. 2021;70:2321-2329.
    >> Share

    November 2021
  74. CASH BD, Fleisher MR, Fern S, Rajan E, et al
    Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study).
    Gut. 2021;70:2115-2122.
    >> Share

    October 2021
  75. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.
    >> Share

    September 2021
  76. KANDIAH K, Subramaniam S, Thayalasekaran S, Chedgy FJ, et al
    Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial).
    Gut. 2021;70:1684-1690.
    >> Share

    July 2021
  77. OSTER P, Vaillant L, Riva E, McMillan B, et al
    Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
    Gut. 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.
    >> Share

  78. WALDMANN E, Penz D, Sinkovec H, Heinze G, et al
    Interval cancer after colonoscopy in the Austrian National Screening Programme: influence of physician and patient factors.
    Gut. 2021;70:1309-1317.
    >> Share

  79. SHAHIDI N, van Hattem WA, Vosko S, Bourke MJ, et al
    Don't judge a book by its cover: except during optical evaluation.
    Gut. 2021;70:1252-1286.
    >> Share

    June 2021
  80. IMPERIALE TF, Monahan PO, Stump TE, Ransohoff DF, et al
    Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults.
    Gut. 2021;70:1155-1161.
    >> Share

    May 2021
  81. RUTTER MD, Evans R, Hoare Z, Von Wagner C, et al
    WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening.
    Gut. 2021;70:845-852.
    >> Share

  82. BIBAULT JE, Chang DT, Xing L
    Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine.
    Gut. 2021;70:884-889.
    >> Share

  83. LO PRESTI E, Corsale AM, Di Simone M, Dieli F, et al
    Characterisation of gammadelta T cells infiltrating colorectal cancer.
    Gut. 2021;70:1001-1003.
    >> Share

    April 2021
  84. ZHAO R, Wan QY, Wu Y, Wang Y, et al
    Crohn's disease instead of UC might increase the risk of small bowel cancer.
    Gut. 2021;70:809-810.
    >> Share

    March 2021
  85. SIRINUKUNWATTANA K, Domingo E, Richman SD, Redmond KL, et al
    Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Gut. 2021;70:544-554.
    >> Share

  86. REYES-URIBE L, Wu W, Gelincik O, Bommi PV, et al
    Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
    Gut. 2021;70:555-566.
    >> Share

    September 2020
  87. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016